Healthcare -
Biotechnology - NASDAQ - US
$ 8.76
-4.38 %
$ 205 M
Market Cap
-8.07
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Nuvectis Pharma, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 19.8 M |
| Operating Income | -19.8 M |
| Other Expenses | -847 K |
| Net Income | -19 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0.1 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0 | 22.9 | 19.2 | 12.9 | 0 |
| Gross Profit | 0 | (22.9) | (19.1) | (12.9) | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 19.8 | 22.9 | 19.2 | 12.9 | 10 K |
| Selling, General and Administrative Expenses | 6.9 | 7.5 | 6.0 | 3.3 | 10 K |
| Research and Development Expenses | 12.9 | 15.4 | 13.2 | 9.5 | 0 |
| Operating Income | (19.8) | (22.9) | (19.2) | (12.9) | 10 K |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0 | 0.1 | 0 | 0 |
| Total Other Income | 0.8 | 0.6 | 0.1 | 4 K | 14 K |
| Pre-Tax Income | (19.0) | (22.3) | (19.1) | (12.9) | 10 K |
| NET INCOME | |||||
| Tax Provision | 0 | 0 | (0.3) | 4 K | 24 |
| Net Income | (19.0) | (22.3) | (18.8) | (12.9) | 10 K |
| EPS | 1.11 | 1.43 | 1.48 | 1.01 | 0.0008 |